Release Details

A scientist inside the laboratory testing specimens

Update on European Medicines Agency Review of Lecanemab Marketing Authorization Application

March 22, 2024

Eisai announced an update on the regulatory review process of lecanemab by the European Medicines Agency (EMA). Additional details can be found in a news release available on Eisai’s website.

Stockholder Communications icon

Stockholder Communications

E-mail Alerts icon

E-mail Alerts

FAQs icon